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Maqola tо‘g‘risida ma’lumot     АННОТАЦИЯ 
Мақсад: экспрементал метаболик синдромли қуёнларда 
кавергални углеводлар ва липидлар алмашинувига таъсирини 
аниқлаш. Материал ва усуллар: эксперимент 18 та қуёнда 
ўтказилди. Метаболик синдром модели Каримов Х.Я. ва авторлар 
тавсиясига кўра амалга оширилди. Кавергални қон зардобидаги 
қанд миқдорига таъсири ўрганилди. Натижа: кавергал билан 
даволанган қуёнларнинг қонида триглицеридлар ва жуда кам 
илипопроте-инлар даражасида сезиларли камайиш кузатилди. 
Дори воситаси қон зардобидаги қанд миқдорига ҳам фойдали 
таъсир кўрсатди. Кавергал милдронатга нисбатан кучлироқ 
гиполипидемик таъсирга эгалиги аниқланди. Хулоса: кавергал 
углевод ҳам липидлар алмашинувига ижобий таъсир килади. 
 
Информация о статье     АННОТАЦИЯ 
Цель: оценка влияния кавергала на показатели углеводного и 
липидного обмена у кроликов с экспериментальным 
метаболическим синдромом. Материал и методы: 
эксперименты проведены на 18 кроликах-самцах, у которых 
согласно рекомендациям Х.Я. Каримова и соавт. создавали 
модель метаболического синдрома Результаты: в крови 
кроликов, леченных кавергалом, наблюдалось достоверное 
уменьшение уровня триглицеридов и липопротеинов очень 
низкой плотности. Препарат оказывал также благоприятное 
влияние на уровень глюкозы сыворотки крови. В отличие от 
милдроната кавергал показал более сильный 
гиполипидемический эффект. Выводы: кавергал оказывает 
положительное действие как на липидный спектр крови, так и 
на степень гипергликемии. 
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Article info       ABSTRACT  
Objective: of the study was to study the effect of kavergal on 
the parameters of carbohydrate and lipid metabolism in 
rabbits with a metabolic syndrome. Material and methods. 
Experiments were performed on 18 rabbits. The model of 
metabolic syndrome was reproduced according to 
H.Ya.Karimov s recommendations. In the course of treatment a 
significant decrease in the level of TG, VHDL and glucose of 
blood in rabbits treated with cavergal. In contrast to 
mildronate, cavergal showed a stronger lipid-lowering effect. 
Conclusion: The results of the study indicate a favorable effect 
of the cavernal both on the lipid spectrum of the blood and on 
the degree of hyperglycemia. 
 
 Changes in the morphology of structures and heart geometry in patients 
with metabolic syndrome (MS) are intermediate mechanisms on the way to more 
severe cardiac function impairment [3]. Therefore, experimental models of MS, 
which make it possible to trace the development of the disease in dynamics, are of 
great interest. 
 There are a number of ways to simulate metabolic disturbances that are 
conditionally adequate to MS, since only individual MS components are 
reproduced in the experimental animal [1,3,4,7,8]. And, finally, the object of 
modeling is not convenient for experimental studies, because, firstly, MS is a 
consequence of rather long metabolic disorders that arise in the body, and 
secondly, to study the dynamics of the disease and evaluate the effectiveness of 
treatment, it is necessary to use the same to animals [2,6,8]. 
 The purpose of this study was to study the effect of cavergal on the 
parameters of carbohydrate, lipid metabolism in rabbits with experimental MS. 
Material and methods. 
The experiments were performed on 18 male rabbits weighing from 1600 to 2100 
g. The MS model was reproduced according to the recommendations of Karimov 
Kh. Ya et al. (2006). This method is protected by the patent of the Republic of 
Uzbekistan [2]. All animals were kept separately, in close cells, in order to create 
hypodynamia. There was a 5% solution of sugar in the animal's bowl, and the 
crystalline cholesterol was mixed daily in the dose of 250 mg / kg of body weight. 
In a day, animals were injected subcutaneously with insulin in a dose of 0.1 units. / 
100 g. 
Adopted: January 2018 
Published: July  2018  
Key words: metabolic syndrome, 
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Simulation of MS lasted 30 days. During the whole experiment, every week all 
animals were weighed and the stomach volume was measured. A month later, on 
the background of further modeling, MS animals were divided into 3 equal groups. 
Rabbits of the 1st group injected a calaban dissolved in distilled water, orally at a 
dose of 50 mg / kg body weight, daily, for 30 days, the 2nd group received a 
mildronate (Grindex, Latvia) at a dose of 50 mg / kg body weight body. In the 3-
group, the MC simulation was continued without experimental therapy. The 
animals that were under ether anesthesia were slaughtered by decapitation on the 
60th day of the experiment. In all animals, initially, on the 30th, 45th and 60th days 
of the experiment, the lipid spectrum, the level of glucose and insulin in the blood 
serum were studied. 
The body mass index of animals was calculated by the formula: M / W, where 
M is the mass of the body in r, W is the waist in cm. The weight gain was 
calculated from the formula: M1-M2, where M1 is the initial weight in g, M2 is the 
body weight per day of the study in g. 
The content of blood glucose was determined on the RANDOX biochemical 
analyzer (Ireland) using special kits and the program. 
The lipid spectrum of blood serum (cholesterol, TG) was also determined on an 
automatic biochemical analyzer RANDOX (Ireland) using special sets and 
programs. The content of cholesterol in HDL was determined in the serum after 
precipitation of LDL cholesterol and very low density lipoproteins with heparin in 
the presence of Mn
2+
 ions. 
The LDL level was calculated according to the formula of Friedwald et al .: 
General Cholesterol - (HDL-C + HD VLDL) 
The content of insulin in the blood was determined on the ELISA enzyme 
immunoassay using special Monobind reagents. 
All digital data was subjected to statistical processing on a Pentium-III computer 
using a software package. The reliability of the differences (P) of the data was 
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calculated using the t-Student test. Differences were considered significant at P 
<0.05. 
Results of the study. 
The results of the study, which characterize the mass and growth indices, are 
presented in Tab. 1. Thus, the weight of untreated animals (group 1) by the end of 
the study significantly exceeded the index of the remaining animals of groups 2 
and 3 (treated with a cavern and a mildronate). The revealed difference was more 
than 40.0 and 30.1%, respectively. 
Table 1. Change in mass and waist in the study groups 
Criteria 
after MS modeling after 1 month of experimental therapy 
1 Group 2 Group 3 Group 
1 Group 
(untreated) 
2 Group 
(kavergal) 
3 Group 
(mildronat) 
The weight, 
kg 
2,32±0,1 2,2±0,13 2,3±0,14 2,97±0,3 1,8±0,19* 2,09±0,16* 
Waist, sm 35,8±2,9 38±1,14 37,4±1,49 41,6±1,21 30,9±1,9* 31,8±1,5* 
Note: * p <0.05 compared with untreated group. 
The waist size of rabbits with MS increased until the end of the experiment, in 
contrast to the treated animals (see Table 1) and exceeded similar values by 25.8% 
in the group with the curved and 23% in rabbits treated with mildronate. Even 
more pronounced differences between the groups we found in studying the lipid 
spectrum of blood serum (Table 2). In the course of treatment, a significant 
decrease in the level of TG and VLDL of blood in rabbits in the 2nd group was 
found to be 43.7% (р0.05) compared with before treatment. In group 3, these 
indicators decreased by 27%, respectively. This difference in values when 
comparing the results in the groups turned out to be reliable (p˂0.05). The 
concentration of cholesterol at the end of the study in animals with MC was 3.6 
times and 1.8 times higher than in the 2nd and 3rd group of subjects (see Table 2). 
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The data obtained on the serum lipid content of untreated rabbits indicate that the 
average indices of atherogenic lipid fractions continued to increase throughout the 
study, and the level of HDL cholesterides tended to slightly increase (see Table 2). 
Criteria 
 
 
after MS modeling 
after 1 month of experimental 
therapy 
1 Group 2 Group 3 Group 
1 Group 
untreated 
2 Group 
kavergal 
3 Group 
mildronat 
Hol, 
mg/dl 
159,1±27,04 160,3±22,1 165,2±5,3 220,8±29,6 60,5±7,6* 119±3,8* 
TG, 
mg/dl 
142,8±33,7 140±31,7 134,6±35,1 173,5±18,2 78,8±6,5* 111,8±10,9* 
HDL, 
mg/dl 
15,6±5,6 15,3±6,12 15,5±6,5 15±3,5 19±2* 21,3±3,07* 
LDL, 
mg/dl 
114,9±24,7 117±21,3 122,7±8,1 153,1±32,0 
25,7±7,9 
* 
75,2±5,4* 
VLDL, 
mg/dl 
28,5±6,7 28±6,3 26,9±7,0 34,7±3,6 15,8±1,3* 22,4±2,3* 
Glucosa, 
mmol/l 
6,98±0,24 7,7±0,42 7,7±0,5 7,9±0,7 6,0±0,05* 6,2±0,1* 
Note: * p <0.05 compared with untreated group, ** p <0.05 compared to pre-
treatment 
 In the study of carbohydrate metabolism, the most favorable effect of 
cavergal on the serum glucose level was found (Table 2). The indicator decreased 
by 22.1%, compared with the level of glucose before treatment (p <0.05). After 1 
month in animals without experimental therapy, there was an increase in serum 
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glucose by 13.1%. That was 24.1% and 21.5% higher than in groups 2 and 3, 
respectively. 
 A similar picture was observed in the level of hyperinsulinemia (GI). Thus, 
the content of insulin in animals of groups 2 and 3 was reduced by 29.5 and 27.3% 
compared to its level before treatment, respectively. At the same time, if in rabbits 
of the 2 group it did not differ much from the norm, in the rabbits of group 3 it was 
still higher than the norm by 31.4%. 
Conclusions 
 Thus, the results of the study indicate a favorable effect of the cavergal 
both on the lipid spectrum of the blood and on the degree of hyperglycemia, GI. In 
contrast to mildronate, cavergal showed a stronger lipid-lowering effect, namely, a 
decrease in Holesterol, TG, LDL. Despite the fact that the points of application of 
both drugs are different [5], they still affect the degree of IR, which is reliably 
expressed in the cavergal. Perhaps it is indirectly associated with its pronounced 
antioxidant, antihypoxic and hypolipidemic properties. 
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